Skip to main content

Myriad Genetics Wins $14.2M NIH Contract to Analyze Host-Pathogen Protein Interactions

NEW YORK, July 8 (GenomeWeb News) - Myriad Genetics has won $14.2 million from the National Institute of Allergy and Infectious Diseases to analyze pathogen-host protein interactions using high-throughput proteomics.


Under the five-year contract, Salt Lake City-based Myriad will use its yeast two-hybrid technology, bioinformatics, and DNA sequencing to conduct proteome-wide analyses of protein interactions between humans and selected pathogens. Myriad also plans to validate these interactions by other methods, such as microbial gene knockout and siRNA.


Myriad will have the rights to commercialize diagnostic and therapeutic targets discovered in the project. All protein interaction and validation data will be made publicly available through the Proteomics Research Program Administrative Center.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.